UNSPSC 51281609: Daptomycin

This classification denotes an aminoglycoside antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier NWQ5N31VKK. European Medicines Agency schedules Daptomycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06910MIG. Daptomycin generally arises in the molecular formula C72H101N17O26.

The term DAPTOMYCIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, no. 3, 1989, list 29.) DAPTOMYCIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule daptomycin under HS 29419000 and SITC 54139. As of Q4 2014, DAPTOMYCIN remains the US FDA Preferred Term for this commodity. Daptomycin bears US NLM identifiers UMLS ID C0057144 and NCI Concept Code C47470.

UNSPSC 51281609 Daptomycin is a Commodity code nominally for a single antibiotic product, but the recent state and local opportunities tagged to it show minimal alignment with that narrow scope. The solicitations under this code predominantly address broader pharmaceutical procurement — generic multi-source drugs, over-the-counter products, naloxone and drug deactivation systems, and medical first aid supplies for emergency response — rather than daptomycin specifically. State and local issuers using this code include county health agencies (Seminole County, Florida), state health departments and cooperative purchasing alliances (Texas Health and Human Services Commission, Minnesota Multistate Cooperative Purchasing Alliance), and municipal fire and rescue departments (City of Tampa). The actual work being procured spans annual standing contracts for emergency pharmaceuticals and supplies, multi-year statewide and multi-state cooperative agreements for generic drug distribution through authorized wholesalers, and exploratory requests for information on direct-to-manufacturer pharmacy programs.

Recent activity is concentrated in Florida, Texas, and Minnesota. The Seminole County IFB (Solicitation IFB60459723LAS, due July 26, 2023) seeks 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, estimated at $700,000 total across medical and first aid supplies per the Tampa Fire Department's parallel IFB (26P00145, due March 13, 2026). The Minnesota Multistate Cooperative Purchasing Alliance RFP (S1070000015802, due March 26, 2026) establishes statewide and multi-state contracts for generic pharmaceuticals and OTC products through three authorized wholesalers, effective July 1, 2026. The Texas HHS Commission issued an RFI (HHS0017013, response due April 3, 2026) to gather vendor capabilities for a direct-to-manufacturer prescription program outside traditional pharmacy benefit manager and wholesaler channels. The code shows active procurement but little genuine daptomycin-specific demand; vendors evaluating this code should assess whether the broader pharmaceutical and emergency medical supply category aligns with their product line.